BioInformatiCo

We interviewed BioInformatiCo's Quality Assurance & Compliance Lead, Dr Robert Kieser, who led the company's ISO/IEC 27001:2022 certification journey.
In wrapping up 2024, we asked the BioInformatiCo team to reflect on what they learnt, what insights they have, what their takeaways are, and what they want to take into the new year.
BioInformatiCo has been ranked in the Sunday Times Top 15 Best Places to Work in South Africa! This incredible recognition is a testament to our commitment to fostering a workplace that prioritises growth, learning and well-being for every member of our team.
In this interview, Dr Nigel Garrett reflects on his journey into HIV research and speaks to us about the science of bNAbs and the work of the BRILLIANT Consortium.
For World AIDS Day this year, we are highlighting the work of the BRILLIANT Consortium, a USAID-funded Cooperative Agreement dedicated to accelerating HIV vaccine discovery and development in Africa. This collaboration between African scientists and institutions is a significant commitment to HIV prevention.
Our team recently had the privilege of attending the HVTN Southern Africa Regional Scientific Meeting in Cape Town. As the appointed data management provider for CoVPN 3008 and CoVPN 3008 TB substudy, it was incredibly rewarding to meet the doctors, scientists, and all the individuals involved in this critical research. Connecting in person reminded us of the shared commitment we all have toward advancing HIV and TB research.
Our team recently attended the SingularityU South Africa Summit, where leaders, tech pioneers and industry experts came together to discuss the transformative power of technology. We left the summit inspired by the future of healthcare both on the African continent and beyond.
We interviewed Professor Linda-Gail Bekker to learn more about her prolific career. Bekker is a Professor of Medicine and Director of the Desmond Tutu HIV Centre at the University of Cape Town. She is also CEO of the Desmond Tutu HIV Foundation. In this interview, she speaks about the current HIV landscape, why HIV vaccines are critical, the importance of collaboration and the exciting work of the BRILLIANT consortium.
We interviewed Professor Glenda Gray to gain more insight on the significance of the USAID-funded BRILLIANT Consortium.
BioInformatiCo is proud to announce our partnership with the BRILLIANT Consortium, a USAID-funded Cooperative Agreement dedicated to accelerating HIV vaccine discovery and development in Africa. This collaboration between African scientists and institutions, led by the South African Medical Research Council (SAMRC), is a significant milestone in the fight against HIV.